Real-World Evidence and Managed Entry Agreements

Real-World Evidence and Managed Entry Agreements

Introduction: Real-World Data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources such as Electronic Health Records (EHRs), data from product and disease Registries, patient generated data, etc. Real-World Evidence (RWE)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Silvia Adami, Cosetta Bianchi, Elisa Crovato, Gianluca Trifirò
Format:	Article
Language:	English
Published:	AboutScience Srl 2025-07-01
Series:	Global & Regional Health Technology Assessment
Subjects:	Managed Entry Agreements Real-World Data Real-World Evidence Registry
Online Access:	https://journals.aboutscience.eu/index.php/grhta/article/view/3563
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of transportability methods for real-world evidence generation: a review of current applications
by: Natalie S Levy, et al.
Published: (2024-10-01)

Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States
by: Xiaofang GU, et al.
Published: (2025-07-01)

Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
by: Chieko Ishiguro, et al.
Published: (2025-12-01)

Real-world evidence market: key players and key segments
by: A. R. Kasimova, et al.
Published: (2022-01-01)

Educational pharmacoepidemiology and "Real-World Knowledge"
by: R. A. Bontsevich
Published: (2025-01-01)

Use of real-world data as pivotal evidence in veterinary regulatory applications
by: Raffaele Bruno
Published: (2025-06-01)

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry
by: Najlae El Ouardi, et al.
Published: (2025-05-01)

ESMO Guidance for Reporting Oncology real-World evidence (GROW)
by: L. Castelo-Branco, et al.
Published: (2023-11-01)

ICH Reflection paper on proposed international harmonization of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data, with a focus on effectiveness of drugs
by: K. S. Radaeva, et al.
Published: (2023-10-01)

Resolution based on the results of the III annual scientific and practical conference «Real clinical practice in a changing world. Challenges and Solutions»
by: A. S. Kolbin
Published: (2022-11-01)

A brief introduction to research based on real-world evidence: Considering the Korean National Health Insurance Service database
by: Eun Kyoung Ahn
Published: (2022-06-01)

Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
by: Katia Thokagevistk, et al.
Published: (2024-05-01)

REAL WORLD EVIDENCE AND BIG DATA
by: Mehmet Güven Günver
Published: (2022-08-01)

Review of data sources used in real-world traumatology and orthopedic
by: I. U. Zolotukhina, et al.
Published: (2023-12-01)

Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
by: Giampiero Girolomoni, et al.
Published: (2024-12-01)

Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
by: Ye-Seul Lee, et al.
Published: (2023-12-01)

Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry
by: Mustafa Yildirim, et al.
Published: (2025-02-01)

Real-world evidence for Pompe disease remains fragmented. Comment on “A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem” by Klein et al.
by: Michelle E. Kruijshaar, et al.
Published: (2025-02-01)

Resolution based on the results of the conference: "RWD/ RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow"
by: A. S. Kolbin
Published: (2021-08-01)

Resolution based on the results of the IV annual scientific-practical conference "Real clinical practice. Modernity and the future"
by: A. S. Kolbin
Published: (2023-12-01)

Erratum: Real-world evidence (RWE): a challenge for regulatory agencies discussion of the RWE conference with the network of the European medicine agencies, patients, and experts
by: Frontiers Production Office
Published: (2025-04-01)

A brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU)
by: A. S. Kolbin, et al.
Published: (2022-01-01)

DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union
by: K. S. Radaeva, et al.
Published: (2023-01-01)

Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
by: T. Macarulla, et al.
Published: (2025-03-01)

Transforming breast cancer management with real-world data and artificial intelligence
by: P. Heudel, et al.
Published: (2024-09-01)

The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01)

Advancing the role of real-world evidence in comparative effectiveness research
by: Monica Daigl, et al.
Published: (2024-10-01)

An overview of real-world study in clinical transfusion
by: GONG Jiashun, et al.
Published: (2025-07-01)

Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany
by: Alastair Greystoke, et al.
Published: (2025-05-01)

Real-world data studies in oncology: analysis of the Russian publications
by: V. F. Achikyan, et al.
Published: (2024-04-01)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
by: Xiaojuan Li, et al.
Published: (2025-04-01)

Resolution based on the results of the V annual scientific-practical conference "RWD/RWE. Possible and real"
by: A. S. Kolbin, et al.
Published: (2024-12-01)

Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer—an international, multicentre, real-world analysis
by: S. Banks, et al.
Published: (2024-03-01)

Requirements and Technical Aspects of Real world Data Governance in China's Medical Standards and Specifications
by: GUAN Xinmiao, et al.
Published: (2024-09-01)

Characterization of psoriasis patients in special body areas: real-world evidence from the Chinese Psoriasis Standardized Diagnosis and Treatment Center
by: Yuge Gao, et al.
Published: (2024-12-01)

Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology
by: Caitlin Clunie-O’Connor, et al.
Published: (2025-07-01)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18
by: Paul Arora, et al.
Published: (2025-02-01)

Real-World Evidence for Comparative Outcomes between Innovator and Biosimilar Bevacizumab in Advanced Colorectal Cancers
by: Arvind Vaidyanathan, et al.
Published: (2024-10-01)

Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
by: Markku Pentikäinen, et al.
Published: (2025-02-01)

Peculiarities of real-world data application for health technology assessment in Asian countries
by: B. B. Kondratyeva, et al.
Published: (2024-02-01)